Large-scale testing (Phase 3)Not Yet RecruitingNCT07392060
What this trial is testing
A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment
Who this might be right for
Cervical Cancer Metastatic
Shanghai Jiatan Pharmatech Co., Ltd 440